drug
tafluprost
Marketedupdated 3mo agoby Thea Pharma Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 3all catalysts(6)
approval · 6
Feb 10, 2012
approval
ZIOPTAN (TAFLUPROST) — FDA approval
tafluprost
→
Feb 22, 2013
approval
ZIOPTAN (TAFLUPROST) — FDA approval
tafluprost
→
Aug 28, 2013
approval
ZIOPTAN (TAFLUPROST) — FDA approval
tafluprost
→
Sep 4, 2015
approval
ZIOPTAN (TAFLUPROST) — FDA approval
tafluprost
→
Sep 4, 2015
approval
ZIOPTAN (TAFLUPROST) — FDA approval
tafluprost
→
Feb 25, 2026
approval
ZIOPTAN (TAFLUPROST) — FDA approval
tafluprost
→
Trials studying tafluprost
Patent cliff
source: FDA Orange Bookfirst barrier falls
May 28, 2029
~2.8 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (2)
- May 28, 2029formulationUS 108641592.8y
- May 28, 2029formulationUS 99995932.8y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 49m ago
Found something off?
comments(0)
5-min edit window · permanent after that